Abbott Spins Out Nutrition, Cannabis Sleep Gummies Face Habit Risk

Abbott is breaking up its nutrition empire — and that reshapes the competitive landscape for every brand in clinical and consumer nutrition. Plus, the cannabis sleep gummy category just got a serious science problem that regulators will notice. In this episode: New research found that a cannabis-derived ingredient common in sleep gummies produces dependency-related patterns with repeated use, threatening one of Europe's fastest-growing supplement formats at a moment of already heightened regulatory scrutiny. A clinical trial found daily vitamin C supplementation improved survival rates in patients with precancerous blood disorders, giving one of the world's most commoditised supplement ingredients its most significant clinical finding in years. UK kefir brand Biotiful Gut Health has launched a full visual identity and packaging overhaul across its entire portfolio, signalling that design differentiation is now a primary competitive weapon in a chilled gut health aisle crowded with own-label rivals. Abbott has announced plans to spin out its nutrition division — home to Ensure, Pedialyte, and Similac — as an independent global company, a move that would create one of the largest standalone nutrition businesses in the world. The Health Marketing Daily is a concise briefing for marketers and founders in supplements, functional food and consumer health, hosted by Marco & Klara. New episode every day. Enjoying the show? A quick rating or review on Apple Podcasts or Spotify helps other marketers find us. Also from Marco & Klara: The FMCG Marketing Daily · The Digital Commerce Daily